Medical Xpress September 3, 2024
Krishna Ramanujan, Cornell University

A new approach to manufacturing cells that secrete and deliver therapies to specific parts of the body has taken a big step toward one day repairing joints and damage after heart attacks, countering transplant rejection and healing currently untreatable lung conditions.

The cells, called mesenchymal stromal cells, can differentiate, like , to become connective tissue cells of cartilage, bone, fat and many organs. They can also be made to secrete mRNA drugs naturally produced by cells to induce repair and then deliver that payload to needed areas using a honing mechanism similar to .

While such cell therapies hold the promise to revolutionize treatment for many disorders, the research faces technology bottlenecks. Scientists have not completely understood the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article